Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma

Recruiting now

Conditions studied: Merkel Cell Carcinoma of Skin

In brief

The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.

Key facts

Study ID

NCT06780475

Run by

Assistance Publique - Hôpitaux de Paris

People needed

15

Starts

2025-05-27

Expected to finish

2027-05-01

Last updated by the study team

2025-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients >= 18 years old;
• Diagnosed with Merkel cell carcinoma of skin, ongoing for local treatment, systemic treatment, complementary treatment or an active follow-up;
• Informed for the study and no-opposed for participation;
• Affiliated with a social security scheme or in an equivalent situation.

You may not qualify if…

• Patients ongoing another interventional clinical trial;
• Patients under guardianship or trusteeship;
• Pregnancy or breastfeed;
• Patients refusal.

Where it is running

• Dermato-oncology Department, Ambroise Paré Hospital, APHP — Boulogne-Billancourt, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.